KLRK1 and lymphoma: NKG2D-deficient (Klrk1−/−) mice are more susceptible to the development of several types of primary tumors, such as a transgene-driven lymphoma and prostate carcinoma, and the overexpression of NKG2D ligands is protective in models of transplanted tumors [14,21,25].